CentriMag RVAS U.S. Post-approval Study Protocol

Location:

Phoenix/Scottsdale, Ariz.

Trial status:

Open for Enrollment

Why is this study being done?

The study objective is to gather post-market clinical data on the use of the CentriMag RVAS when used for temporary mechanical circulatory support of the right ventricle in patients with acute right ventricular failure from any cause

Who is eligible to participate?

Inclusion Criteria: - Right ventricular failure from any cause Exclusion Criteria: - Primary coagulopathy or platelet disorders - Allergy or sensitivity to heparin and all alternative anticoagulants

Last updated:

9/10/2013

NCT ID:

NCT01568424